Covington & Burling advised AstraZeneca on the deal. AstraZeneca (LSE/STO/Nasdaq: AZN) announced its definitive agreement to acquire EsoBiotec SA, a biotechnology company pioneering in vivo cell...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented Siris Capital Group, LLC in the transaction. Equiniti Group plc (EQ), a portfolio company of Siris Capital Group, LLC, announced its entry...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Bristol Myers Squibb on the deal, and Goodwin Procter advised 2seventy bio. Bristol Myers Squibb (NYSE: BMY) (“BMS”) announced its merger agreement...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Flex on the transaction. Flex, a business and personal finance platform, announced its $25 million preferred stock equity financing. The equity funding...
You must be a Standard 1 Year member to access this content.
Gibson Dunn & Crutcher advised Cotiviti on the transaction, Covington & Burling advised Cotiviti, and Kirkland & Ellis advised Francisco Partners and TA Associates on the...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented Samsung Electronics in the transaction. Samsung Electronics, one of the world’s largest chip manufacturers, received $4.745 billion in direct funding under the...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Adiuva Capital on the deal. Tikehau Capital, the global alternative asset management group, announced that its flagship private equity decarbonisation strategy has...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Covington & Burling advised Warburg Pincus and Berkshire Partners on the transaction. Warburg Pincus and Berkshire Partners announced a definitive agreement under...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Lantheus Holdings, Inc. on the deal. Lantheus Holdings, Inc. (Nasdaq: LNTH) (Lantheus) announced its definitive agreement to acquire Life Molecular Imaging Limited,...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented Quanterix Corporation, and DLA Piper represented Akoya Biosciences in the transaction. Skadden represented Goldman Sachs & Co. LLC as financial advisor to...
You must be a Standard 1 Year member to access this content.
Wilmer Cutler Pickering Hale and Dorr represented Trevi Therapeutics, Inc. in the offering, and Covington & Burling represented the underwriters. Trevi Therapeutics, Inc. (Nasdaq: TRVI), a...
You must be a Standard 1 Year member to access this content.
Covington & Burling and Troutman Pepper Hamilton Sanders advised Quikrete Holdings, Inc. on the transaction, and Davis Polk & Wardwell advised Summit Materials, Inc. Quikrete Holdings,...
You must be a Standard 1 Year member to access this content.
